Whereas co-occurring TP53 mutations are associated with inflammatory tumor microenvironment and higher levels of PD-L1 expression, STK11/LKB1 and KEAP1 mutations correlate with immunosuppressive tumor microenvironment and shorter survival [55,56]. This evidence concerns the gene TP53 and neoplasm.